Simon Rule, MD^1*, Wojciech Jurczak, MD, PhD², Mats Jerkeman, MD, PhD³, Rodrigo Santucci, MD⁴, Chiara Rusconi, MD^5*, Marek Trneny, M.D., Ph.D., Prof.⁶, Fritz Offner, MD, PhD⁷, Dolores Caballero, MD^8*, Cristina Joao, MD, PhD, MSc^9*, Mathias Witzens-Harig, MD^10*, Georg Hess, MD^11*, Isabelle Bence-Bruckler, MD, FRCPC^12*, Seok-Goo Cho, M.D.¹³, Sriram Balasubramanian, PhD¹⁴, Nibedita Bandyopadhyay, PhD^15*, Steven Sun, PhD^15*, Jenna Goldberg, MD^15*, John Bothos, PhD^15*, Christopher Enny, BS^15*, Shana Traina, PhD^16*, Aleksandra Rizo, MD^15*, Jessica Vermeulen, MD, PhD^17* and Martin H. Dreyling, MD, PhD¹⁸

¹Department of Haematology, Derriford Hospital, Plymouth, United Kingdom
²Dept of Hematology, Jagiellonian University, Krakow, Poland
³Department of Oncology, Skåne University Hospital, Lund University, Lund, Sweden
⁴HEMOMED, São Paulo, Brazil
⁵Division of Hematology, Niguarda Ca' Granda Hospital, Milan, Italy
⁶First Dep. of Medicine, Charles University General Hospital, Prague, Czech Republic
⁷University Hospital Gent, Gent, Belgium
⁸Hospital Universitario de Salamanca, Salamanca, Spain
⁹Hematologist, Fundação Champalimaud, Lisbon, Portugal
¹⁰Dep. Med. V, University Hospital Heidelberg, Heidelberg, Germany
¹¹Department of Internal Medicine III (Hematology, Oncology, Pneumology), University Medical Center of the Johannes Gutenberg-University, Mainz, Germany
¹²Division of Hematology, The Ottawa Hospital, Ottawa, ON, Canada
¹³Department of Hematology, Catholic Blood and Marrow Transplantation Center, Cancer Research Institute, Seoul St. Mary’s hospital, College of Medicine, The Catholic University of Korea, Seoul, South Korea
¹⁴Janssen Research & Development, Springhouse, PA
¹⁵Janssen Research & Development, Raritan, NJ
¹⁶Janssen Pharmaceutical Research & Development, Raritan, NJ
¹⁷Janssen Pharmaceutical Research & Development, Leiden, Netherlands
¹⁸Dept. of Medicine III, Univ. Hospital Grosshadern/LMU, Munich, Germany

Nathan Fowler, MD¹, Loretta Nastoupil, MD², Sven de Vos, MD, PhD³, Mark Knapp, MD⁴, Ian W. Flinn, MD, PhD⁵, Robert Chen⁶, Ranjana H Advani, MD⁷, Sumeet Bhatia, MD^8*, Peter Martin, MD⁹, Raul Mena, MD¹⁰, Samuel Suzuki, MS, MBA^11*, Darrin M. Beaupre, MD¹¹, Jutta K. Neuenburg, MD^11* and M. Lia Palomba, MD¹²

¹Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
²University of Texas MD Anderson Cancer Center, Houston, TX
³Division of Hematology/Oncology, David Geffen School of Medicine at UCLA, Los Angeles, CA
⁴Mid Ohio Oncology/Hematology, Inc., Columbus, OH
⁵Hematologic Malignancies Research Program, Sarah Cannon Research Institute, Nashville, TN
⁶City of Hope National Medical Center, Duarte, CA
⁷School of Medicine, Dept of Medical Oncology, Stanford University Medical Center, Stanford, CA
⁸Community Health Network, Indianapolis, IN
⁹Weill Cornell Medical College, New York, NY
¹⁰Providence Saint Joseph Medical Center/Disney Family Cancer Center, Burbank, CA
¹¹Pharmacyclics LLC, an AbbVie Company, Sunnyvale, CA
¹²Department of Medicine, Lymphoma Service, Memorial Sloan Kettering Cancer Center, New York, NY

Chaitra S. Ujjani, MD¹, Sin-Ho Jung, PhD^2*, Brandelyn Pitcher, MS^3*, Peter Martin, MD⁴, Steven I. Park, MD⁵, Kristie A. Blum, MD⁶, Sonali M. Smith, MD⁷, Myron S. Czuczman, MD⁸, Matthew S. Davids, MD⁹, John P. Leonard, MD¹⁰ and Bruce D. Cheson, MD¹

¹Lombardi Comprehensive Cancer Center, Georgetown University Hospital, Washington, DC
²Alliance Statistics and Data Center, Duke University, Durham, NC
³Duke University Medical Center, Durham, NC
⁴Division of Hematology/Oncology, Weill Cornell Medical College, New York, NY
⁵Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC
⁶Division of Hematology, The Ohio State University, Columbus, OH
⁷University of Chicago, Chicago, IL
⁸Celgene Corporation, Summit, NJ
⁹Dana-Farber Cancer Institute, Boston, MA
¹⁰Department of Medicine, Weill Cornell Medical College, New York, NY

Kieron Dunleavy, MD¹, Catherine E. Lai, MD², Mark Roschewski, MD¹, Jennifer N Brudno, MD³, Brigitte Widemann, MD^4*, Stefania Pittaluga, MD, PhD⁵, Elaine S Jaffe, MD⁵, Andrea N Lucas, RN^3*, Maryalice Stetler-Stevenson, MD, PhD⁵, Constance M. Yuan, MD, PhD^5*, Pamela Harris, MD^6*, Diane Cole^4*, John A Butman, MD^3*, Richard F Little, MD^6*, Louis M Staudt, MD¹ and Wyndham H Wilson, MD, PhD¹

¹Lymphoid Malignancies Branch, National Cancer Institute, Bethesda, MD
²Myeloid Malignancies Section, Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD
³Center for Cancer Research, National Cancer Institute, Bethesda, MD
⁴Pediatric Oncology Branch, National Cancer Institute, Bethesda, MD
⁵Laboratory of Pathology, National Cancer Institute, Bethesda, MD
⁶Cancer Therapy Evaluation Program, National Cancer Institute, Rockville, MD

Vincent Ribrag¹, Jean-Charles Soria, Professor^1*, Jean-Marie Michot^2*, Anna Schmitt, MD^3*, Sophie Postel-Vinay, MD^1*, Fontanet Bijou, MD⁴, Blythe Thomson, MD⁵, Heike Keilhack, PhD^5*, Stephen J. Blakemore, PhD^5*, Larisa Reyderman, PhD^6*, Pavan Kumar, PhD^7*, Greg Fine, MS^5*, Alice McDonald^5*, Peter T Ho, PhD, MD⁵ and Antoine Italiano, MD^3*

¹Institut Gustave Roussy, Villejuif, France
²Gustave Roussy Comprehensive Cancer Center, Villejuif, France
³Institut Bergonie, Bordeaux, France
⁴French Blood Institute, Bordeaux, France
⁵Epizyme, Inc, Cambridge, MA
⁶Eisai, Inc, Woodcliff Lake, NJ
⁷Eisai, Inc, Andover

Norbert Schmitz, MD, PhD¹, Maike Nickelsen, MD^2*, Marita Ziepert, PhD^3*, Mathias Haenel, MD^4*, Andreas Viardot, MD^5*, Martin H. Dreyling, MD, PhD⁶, Peter Borchmann, MD⁷, Carsten Bokemeyer, MD^8*, Christian Peschel, MD⁹, Hans-Heinrich Wolf, MD^10*, Rolf Mahlberg, MD^11*, Michael Pfreundschuh, MD¹² and Bertram Glass, MD^13*

¹On behalf of the German High Grade Non-Hodgkin-Lymphoma Study Group (DSHNHL), Hamburg, Germany
²Department Hematology, Oncology and Stem Cell Transplantation, Asklepios Hospital St.. Georg, Hamburg, Germany
³Institute for Medical Informatics, Statistics, and Epidemiology, University of Leipzig, Germany, Leipzig, Germany
⁴Klinikum Chemnitz, Chemnitz, Germany
⁵University Hospital of Ulm, Ulm, Germany
⁶Dept. of Medicine III, Univ. Hospital Grosshadern/LMU, Munich, Germany
⁷Department I of Internal Medicine and German Hodgkin Study Group (GHSG), University Hospital of Cologne, Cologne, Germany
⁸II. Medizinische Klinik und Poliklinik, Universitätsklinikum Eppendorf, Hamburg, Germany
⁹III. Medizinische Klinik, Klinikum rechts der Isar, Technical University Munich, Munich, Germany
¹⁰Department of Hematology and Oncology, University Hospital, Halle, Germany
¹¹Mutterhaus der Boromaerinnen, Trier, Germany
¹²Department of Internal Medicine I, Saarland University Medical School, Homburg, Germany
¹³Hematology, Oncology and Stem Cell Transplantation, Asklepios Hospital St Georg, Hamburg, Germany